Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Noguchi, T.
Right arrow Articles by Takeno, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Noguchi, T.
Right arrow Articles by Takeno, S.
Related Collections
Right arrow Prognostic factors
Annals of Surgical Oncology 9:1017-1022 (2002)
© 2002 Society of Surgical Oncology

ORIGINAL ARTICLES

DNA-PKcs Expression in Esophageal Cancer as a Predictor for Chemoradiation Therapeutic Sensitivity

Tsuyoshi Noguchi, MD, Tomotaka Shibata, MD, Shoichi Fumoto, MD, Yuzo Uchida, MD, Wolfram Mueller, MD and Shinsuke Takeno, MD

From the Department of Oncological Science (Surgery II) (TN, TS, SF, YU, ST), Oita Medical University, Oita, Japan; and the Institute of Pathology (WM), Heinrich-Heine University, Düsseldorf, Germany.

Correspondence: Address correspondence and reprint requests to: Shinsuke Takeno, MD, Department of Oncological Science (Surgery II), Oita Medical University, Idaigaoka 1-1, Hasama-machi, 879-5593 Oita, Japan; Fax: 81-97-549-4449; E-mail: surg2{at}oita-med.ac.jp

Background: It would be of considerable benefit to patients with esophageal cancer to be able to predict the effect of CRT before therapy, because critical side effects could be avoided and the therapeutic cost of CRT-resistant cases could be reduced. One of the biological parameters with the potential to indicate radioresponse is the DNA double-strand break repair enzyme DNA-PKcs. This study aims to clarify the correlation between DNA-PKcs expression and CRT effect.

Methods: Sixty-seven patients with progressive esophageal cancer treated with CRT were included in this study. The relationship between the expression of DNA-PKcs and the effect of CRT was examined by using immunohistochemistry. The relationships between DNA-PKcs expression, clinicopathologic parameters, and CRT effect were investigated statistically.

Results: A significant correlation was found between the expression of DNA-PKcs and the effect of CRT (P = .0149). The high—DNA-PKcs expression group showed greater therapeutic sensitivity than the low-expression group. Clinicopathologic factors had no relationship with DNA-PKcs expression or CRT effect.

Conclusions: This study suggests that high expression of DNA-PKcs correlates with CRT effect. DNA-PKcs expression could, therefore, be useful for predicting the effect of CRT. In addition, these results may make it possible to plan therapy taking patients’ quality of life into consideration.

Key Words: DNA-PKcs • Esophageal cancer • Chemoradiotherapy • Immunohistochemistry




This article has been cited by other articles:


Home page
 Molecular Cancer TherapeuticsHome page
T. Y-K. Chow, M. A. Alaoui-Jamali, C. Yeh, L. Yuen, and D. Griller
The DNA double-stranded break repair protein endo-exonuclease as a therapeutic target for cancer
Mol. Cancer Ther., August 1, 2004; 3(8): 911 - 920.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society of Surgical Oncology.